Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 66Rectal Neoplasms 9Carcinoma, Non-Small-Cell Lung 8Triple Negative Breast Neoplasms 7Lung Neoplasms 6Adenocarcinoma of Lung 6Carcinoma, Intraductal, Noninfiltrating 5Breast Carcinoma In Situ 4Pancreatic Neoplasms 2Unilateral Breast Neoplasms 1Transsexualism 1Solitary Pulmonary Nodule 1Social Isolation 1Recurrence 1Piebaldism 1Patient Satisfaction 1Pain, Postoperative 1Neoplastic Cells, Circulating 1Neoplasm Micrometastasis 1Margins of Excision 1Lymphedema 1Local Recurrence of Malignant Tumor of Breast 1Inflammatory Breast Neoplasms 1Gynecomastia 1Gastrointestinal Stromal Tumors 1Chordoma 1Carcinoma, Lobular 1Carcinoma, Ductal, Breast 1Carcinoma, Ductal 1COVID-19 1

Interventions

Radiotherapy 4Carboplatin 4Trastuzumab 3Fulvestrant 3Cyclophosphamide 3Chemotherapy, Adjuvant 3Paclitaxel 2Magnetic Resonance Spectroscopy 2Letrozole 2Docetaxel 2repotrectinib 1proto-oncogene protein c-fes-fps 1palbociclib 1neratinib 1gallium 68 PSMA-11 1fluciclovine F-18 1entrectinib 1Zolpidem 1Vorinostat 1Vinorelbine 1Venlafaxine Hydrochloride 1Thiotepa 1Taxes 1Tamoxifen 1Sugars 1Sampling Studies 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy, Conformal 1Radiotherapy, Adjuvant 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Lobular × Mastectomy, Segmental × Clear all
NCT05919108 2025-09-09

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

Vanderbilt-Ingram Cancer Center

Phase 2 Recruiting
30 enrolled

Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡